Childhood Asthma, a chronic condition, is frequently reported. International guidelines for children and young people (CYP) support using Leukotriene receptor antagonists (LTRAs) however they are often debated for their potential adverse effects. Thus a study investigated the reported frequency of adverse drug reactions (ADRs) from LTRAs in CYP with asthma by exploring Embase, MEDLINE, PubMed and CINAHL.
Eligible studies underwent assessment for the risk of bias or quality of data.
Thus LTRAs can produce a spectrum of ADRs in CYP, especially gastrointestinal and neuropsychiatric disorders. Hence CYP with asthma must be monitored carefully to assess and manage ADRs and to terminate the treatment when clinically stable.
Dixon EG, Rugg-Gunn CE, Sellick V, et al. Adverse drug reactions of leukotriene receptor antagonists in children with asthma: a systematic review. BMJ Paediatrics Open 2021;5:e001206. doi: 10.1136/bmjpo-2021-001206
Subscribe To Our Newsletter
Filter out the noise and nurture your inbox with health and wellness advice that's inclusive and rooted in medical expertise.
Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks
Please update your details